Home Search
pancreatic cancer - search results
If you're not happy with the results, please do another search
First steps towards a vaccine for pancreatic cancer achieved
Researchers have developed a personalised vaccine system that could delay the onset of pancreatic cancer.
The study, conducted by researchers from Queen Mary University of...
Clinical trials anticipated for treating pancreatic cancer with cannabis
A flavonoid of cannabis – FBL-03G – has been granted Orphan drug status by the United States Food and Drug Administration.
It is anticipated this...
Cannabis flavonoid could help treat pancreatic cancer
A recent study has concluded that a non-cannabinoid, non-psychoactive cannabis flavonoid, FBL-03G, has the potential to treat pancreatic cancer.
The study, conducted by researchers with...
Could inflammation be the key to pancreatic cancer prevention?
Health Europa presents recent research from the Spanish National Cancer Research Centre that has revealed an unexpected link between pancreatic cancer and inflammation.
Pancreatic cancer...
Advanced pancreatic cancer: is killer cell-based immunotherapy a potential cure?
New cell-based immunotherapy research led to the eradication of advanced pancreatic cancer cells, including cancer cells that had already spread to the liver and...
Could pancreatic cancer be blocked?
Researchers have developed a new drug that has the ability to prevent pancreatic cancer growth and potentially block the cancer cells from growing.
The study,...
A way of detecting pancreatic cancer at its earliest stages has been found
Previously, detecting pancreatic cancer has been proven to be difficult and is usually diagnosed very late in the disease progression. However, a newly developed...
Pancreatic cancer signs could be spotted in Type 2 diabetes diagnosis
Recent onset of Type 2 diabetes could give indication of pancreatic cancer signs, according to new research in the Journal of the National Cancer...
A platform for pancreatic cancer
Pancreatic cancer is set to be Europe’s second leading cause of cancer death by 2020. Why, then, is funding so low? Pancreatic Cancer Europe...
Defence’s ARM-X vaccine completely inhibits ovarian cancer growth in treated animals
Defence Therapeutics Inc., a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that its second-generation ARM-X anti-cancer...
ARM-002TM anti-cancer vaccine shows promise in combatting pre-established melanoma
Defence Therapeutics Inc. has unveiled the exceptional efficacy of its second-generation ARMTM anti-cancer vaccine.
The anti-cancer vaccine, dubbed ARM-002TM, has demonstrated proficiency in combating pre-established...
Defence Therapeutics announces successful ARM-002TM cancer vaccine results
Defence Therapeutics has announced the successful testing of its second-generation anti-cancer vaccine, named ARM-002TM, utilising its flagship anti-cancer molecule, AccuTOX®.
The ARM-002TM cancer vaccine, when...
NHS introduces routine bowel cancer screening for Lynch syndrome patients
The NHS has announced it is offering routine bowel cancer screening to thousands of individuals with Lynch syndrome.
BRCA gene testing programme launched by NHS to identify cancer risk
Tens of thousands of people with Jewish ancestry are set to benefit from a pioneering BRCA gene testing programme unveiled by the NHS.
The BRCA...
AccuTOX® anticancer drug demonstrates exciting antigen cross-presentation
Defence Therapeutics Inc., a prominent Canadian biopharmaceutical company renowned for its work in immune-oncology vaccines and drug delivery technologies, has announced the discovery of...
How Defence’s Accum® technology is advancing cancer therapeutics
Industry-leading biotechnology pioneer Defence Therapeutics details how the company is advancing immune oncology through its revolutionary Accum® technology.
Whether using an antibody, cell-based vaccine or...
Striving for more in cancer care and prevention
Despite vast improvements in cancer care, challenges remain in driving forward cancer prevention strategies.
UK lung cancer death rates are predicted to fall in 2023
A new study by the University of Milan has found that cancer death rates will fall by 6.5% in men and 3.7% in women.
A...
The University of Glasgow to receive £1.7m funding to explore the causes of cancer
Scientists are set to receive £1.7 million from Cancer Research UK to investigate the root causes of cancer and how to improve treatments.
Cancer is...
High-precision medicine can improve treatment for ovarian cancer
An international team of researchers have found that high-precision medicines can be used in oncology, allowing for better treatment for ovarian cancer.
Mutations of BRCA1...